EPIRUBICIN IN NON-HODGKINS LYMPHOMAS

被引：12

作者：

LOPEZ, M ^{[1
]}

DILAURO, L ^{[1
]}

GANZINA, F ^{[1
]}

PERNO, CF ^{[1
]}

PAPALDO, P ^{[1
]}

DIPIETRO, N ^{[1
]}

机构：

[1] FARMITALIA CARLO ERBA,THERAPEUT RES DEPT,MILAN,ITALY

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1985年 / 8卷 / 02期

关键词：

D O I：

10.1097/00000421-198504000-00008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：151 / 153

页数：3

共 9 条

[1] SYNTHESIS AND ANTITUMOR PROPERTIES OF NEW GLYCOSIDES OF DAUNOMYCINONE AND ADRIAMYCINONE [J].

ARCAMONE, F ;

PENCO, S ;

VIGEVANI, A ;

REDAELLI, S ;

FRANCHI, G ;

DIMARCO, A ;

CASAZZA, AM ;

DASDIA, T ;

FORMELLI, F ;

NECCO, A ;

SORANZO, C .

JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (07) :703-707

[2]

BENDER RA, 1978, RANDOMIZED TRIALS CA, P77

[3] ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].

BLUM, RH ;

CARTER, SK .

ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :249-259

[4] TOXIC AND THERAPEUTIC ACTIVITY OF 4'-EPI-DOXORUBICIN [J].

BONFANTE, V ;

VILLANI, F ;

BONADONNA, G .

TUMORI JOURNAL, 1982, 68 (02) :105-111

[5]

CARBONE PP, 1971, CANCER RES, V31, P1860

[6]

CASAZZA AM, 1978, CURRENT CHEMOTHERAPY, P1257

[7] 4'-EPI-DOXORUBICIN, A NEW ANALOG OF DOXORUBICIN - A PRELIMINARY OVERVIEW OF PRE-CLINICAL AND CLINICAL-DATA [J].

GANZINA, F .

CANCER TREATMENT REVIEWS, 1983, 10 (01) :1-22

[8] TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].

OKEN, MM ;

CREECH, RH ;

TORMEY, DC ;

HORTON, J ;

DAVIS, TE ;

MCFADDEN, ET ;

CARBONE, PP .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655

[9]

Rappaport H, 1966, ATLAS TUMOUR PATHOLO

← 1 →